Literature DB >> 20627830

The epigenetics of breast cancer.

Jovana Jovanovic1, Jo Anders Rønneberg, Jörg Tost, Vessela Kristensen.   

Abstract

Epigenetic changes can be defined as stable molecular alterations of a cellular phenotype such as the gene expression profile of a cell that are heritable during somatic cell divisions (and sometimes germ line transmissions) but do not involve changes of the DNA sequence itself. Epigenetic phenomena are mediated by several molecular mechanisms comprising histone modifications, polycomb/trithorax protein complexes, small non-coding or antisense RNAs and DNA methylation. These different modifications are closely interconnected. Epigenetic regulation is critical in normal growth and development and closely conditions the transcriptional potential of genes. Epigenetic mechanisms convey genomic adaption to an environment thereby ultimately contributing towards given phenotype. In this review we will describe the various aspects of epigenetics and in particular DNA methylation in breast carcinogenesis and their potential application for diagnosis, prognosis and treatment decision. (c) 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20627830      PMCID: PMC5527941          DOI: 10.1016/j.molonc.2010.04.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  121 in total

1.  Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.

Authors:  Annie Hurtubise; Richard L Momparler
Journal:  Cancer Chemother Pharmacol       Date:  2006-06-17       Impact factor: 3.333

Review 2.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

Authors:  D D'Amours; S Desnoyers; I D'Silva; G G Poirier
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

3.  Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

Authors:  M Esteller; J M Silva; G Dominguez; F Bonilla; X Matias-Guiu; E Lerma; E Bussaglia; J Prat; I C Harkes; E A Repasky; E Gabrielson; M Schutte; S B Baylin; J G Herman
Journal:  J Natl Cancer Inst       Date:  2000-04-05       Impact factor: 13.506

4.  Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13.

Authors:  M J Seraj; R S Samant; M F Verderame; D R Welch
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

5.  DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.

Authors:  K D Robertson; S Ait-Si-Ali; T Yokochi; P A Wade; P L Jones; A P Wolffe
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

6.  Methylation of the BRCA1 gene in sporadic breast cancer.

Authors:  A Dobrovic; D Simpfendorfer
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

7.  Hypermethylation in histologically distinct classes of breast cancer.

Authors:  Young Kyung Bae; Amy Brown; Elizabeth Garrett; Daniel Bornman; Mary Jo Fackler; Saraswati Sukumar; James G Herman; Edward Gabrielson
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

8.  Promoter-dependent mechanism leading to selective hypomethylation within the 5' region of gene MAGE-A1 in tumor cells.

Authors:  Charles De Smet; Axelle Loriot; Thierry Boon
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

9.  Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.

Authors:  Madhavi Billam; Michele D Sobolewski; Nancy E Davidson
Journal:  Breast Cancer Res Treat       Date:  2009-05-21       Impact factor: 4.872

10.  DNA methylation in serum of breast cancer patients: an independent prognostic marker.

Authors:  Hannes M Müller; Andreas Widschwendter; Heidi Fiegl; Lennart Ivarsson; Georg Goebel; Elisabeth Perkmann; Christian Marth; Martin Widschwendter
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

View more
  111 in total

1.  On the molecular biology of breast cancer.

Authors:  Anne-Lise Børresen-Dale; Therese Sørlie; Vessela N Kristensen
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

Review 2.  The epigenetics of breast cancer.

Authors:  Jovana Jovanovic; Jo Anders Rønneberg; Jörg Tost; Vessela Kristensen
Journal:  Mol Oncol       Date:  2010-04-29       Impact factor: 6.603

3.  Tumor suppressor function of RUNX3 in breast cancer.

Authors:  Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

4.  Associations between genetic variation in one-carbon metabolism and LINE-1 DNA methylation in histologically normal breast tissues.

Authors:  Adana A M Llanos; Catalin Marian; Theodore M Brasky; Ramona G Dumitrescu; Zhenhua Liu; Joel B Mason; Kepher H Makambi; Scott L Spear; Bhaskar V S Kallakury; Jo L Freudenheim; Peter G Shields
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

Review 5.  Carcinogenicity of ambient air pollution: use of biomarkers, lessons learnt and future directions.

Authors:  Christiana A Demetriou; Paolo Vineis
Journal:  J Thorac Dis       Date:  2015-01       Impact factor: 2.895

6.  DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.

Authors:  Catherine L Callahan; Youjin Wang; Catalin Marian; Daniel Y Weng; Kevin H Eng; Meng-Hua Tao; Christine B Ambrosone; Jing Nie; Maurizio Trevisan; Dominic Smiraglia; Stephen B Edge; Peter G Shields; Jo L Freudenheim
Journal:  Epigenetics       Date:  2016-05-31       Impact factor: 4.528

7.  Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways.

Authors:  Hong Zong; Feng Wang; Qing-Xia Fan; Liu-Xing Wang
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

8.  The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer.

Authors:  Da Wang; Changlong Li; Xuemei Zhang
Journal:  DNA Cell Biol       Date:  2014-05-19       Impact factor: 3.311

9.  Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.

Authors:  Debra Lyon; Lynne Elmore; Noran Aboalela; Jacqueline Merrill-Schools; Nancy McCain; Angela Starkweather; R K Elswick; Colleen Jackson-Cook
Journal:  Biol Res Nurs       Date:  2013-04-11       Impact factor: 2.522

10.  PELP1 oncogenic functions involve CARM1 regulation.

Authors:  Monica Mann; Valerie Cortez; Ratna Vadlamudi
Journal:  Carcinogenesis       Date:  2013-03-13       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.